Masin-Spasovska Jelka, Dimitrovski Koco, Stavridis Sotir, Stankov Oliver, Dohcev Saso, Saidi Skender, Jakovski Krume, Balkanov Trajan, Labacevski Nikola, Stankov Viktor, Lekovski Ljupco, Spasovski Goce
University Department of Nephrology, Ss Cyril and Methodius University, Skopje, Republic of Macedonia.
Curr Drug Saf. 2013 Apr;8(2):141-4. doi: 10.2174/15748863113089990026.
A liver dysfunction induced by halogenated volatile anaesthetics is considered as a significant diagnostic problem. The aim of our report was to describe the first case of lethal hepatic failure in a female patient undergoing kidney transplantation (KTx) from a living donor after repeated sevoflurane anaesthesia.
A 47-year-old hypertensive and diabetic female patient received kidney from her 70-year-old mother. There was an immediate graft function and around 800 ml of blood loss on the abdominal drains, which gradually decreased after the erythrocyte and fresh frozen plasma (FFP) substitution. On the first postoperative (p.o.) day she gradually became anuric and overweighed at the next day undergoing dialysis. Because of prolonged hypotension and somnolence she required reintubation. The second day transaminases increased (AST&ALT>700, LDH>1200 U/L). On the third p.o. day she was urgently reoperated because of a sudden excessive bleeding. However, there was a rather slow flow of tears from the whole operative field that was even more excessive after the operation with signs of a consumptive coagulopathy. She was adequately substituted until the bleeding stopped more than 24 hrs after its onset. The new laboratory results showed further increase in transaminazes (3300 U/L-ALT, 5100-AST, 8900-LDH) and ultrasound investigation confirmed an extensive toxic hepatic lesion. On the fourth p.o. night the patient was stable, diuresis rate was at 100 ml/hour, but in the morning she became hyposaturated because of an increased bronchial secretion. The dialysis could not improve the cardio-respiratory insufficiency and she died 30min later.
This case report suggests that sevoflurane can lead to a severe hepatotoxicity in at-risk individuals with repeated sevoflurane anaesthesia, having renal failure, in those with a preoperative known history of cardiovascular disorders, as well as in those with excessive extracellular volume. A particular precaution should be considered in cases of an elective surgery including organ transplantation.
卤代挥发性麻醉剂引起的肝功能障碍被认为是一个重大的诊断问题。我们报告的目的是描述首例在活体供肾肾移植(KTx)女性患者中,反复使用七氟烷麻醉后发生致死性肝衰竭的病例。
一名47岁患有高血压和糖尿病的女性患者接受了来自其70岁母亲的肾脏。移植肾立即发挥功能,腹腔引流管引流出约800毫升血液,在输注红细胞和新鲜冰冻血浆(FFP)后逐渐减少。术后第一天,她逐渐无尿,第二天体重增加并接受透析。由于长时间低血压和嗜睡,她需要重新插管。第二天转氨酶升高(AST和ALT>700,LDH>1200 U/L)。术后第三天,由于突然大量出血,她接受了紧急再次手术。然而,整个手术区域渗血缓慢,术后渗血甚至更多,并出现消耗性凝血病迹象。在出血开始24小时多后出血停止前,她得到了充分的替代治疗。新的实验室检查结果显示转氨酶进一步升高(ALT 3300 U/L、AST 5100 U/L、LDH 8900 U/L),超声检查证实存在广泛的中毒性肝损伤。术后第四天夜间患者情况稳定,尿量为100毫升/小时,但早晨因支气管分泌物增多出现低氧饱和度。透析无法改善心肺功能不全,30分钟后患者死亡。
本病例报告提示,七氟烷在有肾衰竭、术前有心血管疾病史以及细胞外液过多的高危个体中,反复使用七氟烷麻醉可导致严重肝毒性。在包括器官移植在内的择期手术中应特别谨慎。